05-06-2026 11:45 via drugs.com

Two-Pill Combo Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML

FRIDAY, June 5, 2026— An already available two-pill combo treats leukemia just as well as IV drugs, which should make cancer treatment easier on older adults, a new clinical trial has concluded.The combo – decitabine-cedazuridine and venetoclax –...
Read more »

Pharmaceutical news



Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
ASCO: Tile-Based Radiation Beneficial for Newly Resectable Brain Mets
ASCO: Apalutamide + ADT Beneficial in High-Risk Localized Prostate Cancer
Wearable Ultrasound Patch Provides Continuous Fetal Monitoring
Cardiometabolic Genetics Linked to Cognitive-Related Outcomes
Dose Reduction of Biologics Effective, Safe for Psoriasis
Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
Spinal Cord Stimulation May Restore Arm Strength After Stroke
Popular Blood Pressure Meds Linked To Kidney Damage Risk In Type 2 Diabetes
Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
Too Much Sitting In Pregnancy Doubles Risk Of Complications
RFK Jr. Seeks To Peek At Americans' Medical Records For Clues On Autism And Vaccines
Two-Pill Combo, Inqovi and Venclexta, Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML
High Prevalence of Clinical Obesity Seen Even With Normal BMI
Desktop versie